Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Pioneer Group drives AI innovation in healthcare through industry and academic collaboration

Pioneer Group, the life science infrastructure and venture building specialist, has joined forces with Innovate UK, The Medical Research Council (MRC) and AstraZeneca, to deliver the AI in Health Accelerator 2024/2025 Programme.

The Accelerator is designed to help entrepreneurs confidently market their AI-driven healthcare solutions and accelerate novel technology development time to market. The partners will collaborate across all elements of the Accelerator Programme, including its design and operation.

Applications are now open for Accelerate@Babraham – your opportunity to be part of one of the best Campus’ across the UK and Europe to start-up a life science venture

Starting something new is hard – particularly within the fast-moving life science sector. Step forward Accelerate@Babraham, the Babraham Research Campus’ bio-incubator, founded out of a desire to support and nurture early-stage ventures; bringing to bear an unrivalled network of experts, mentors and investors and data-driven, comprehensive business analysis and support to equip these young enterprises with the skills, confidence and network connections to enable success.

Finance and HR Administrator

About Healx
There are 10,000 known rare diseases that affect 400 million people across the globe, and 95% of them have no approved treatment. We’re on a mission to change that.

We are pioneering the next generation of drug discovery by applying frontier AI technology to accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact.

Medicines Discovery Catapult Strengthens Senior Leadership Team with Two Executive Appointments

Medicines Discovery Catapult (MDC), a national Life Sciences service dedicated to driving productivity and impact in drug R&D, has strengthened its Executive team with the appointment of a Chief Commercial Officer and its first Managing Director.

Dr Francesca Sadler has joined MDC as Chief Commercial Officer, bringing over 20 years’ experience in commercialising high-quality scientific services to both UK and international communities.

Nordic Life Science Days 2025 (NLSDays)

Where Nordic life science meets the world

Nordic Life Science Days is the largest life science partnering event in the Nordics. NLSDays gathers big pharma executives, investors and CEOs of biotech, pharma and medtech companies and discusses the road ahead for the life science industry. 2024 numbers: • Attracted 1400+ delegates from 30 countries. • Gathered 150+ investors and 120+ speakers and presenters • Gathered 130+ showcasing companies, organizations, and countries. • Enjoyed the support of more than 80 sponsors and partners. 

Optimized plating of bacterial and yeast cells on standard agar plates

EZ-Spread™ Plating Beads from AMSBIO allow you to spread bacterial and yeast cells across the surface of an agar plate in just seconds.

Eliminating the traditional need for glass rods and potentially hazardous ethanol flaming - EZ-Spread plating beads provide a safer and more convenient method for spreading bacterial and yeast cells on agar plates.

Manufactured using precision molds, resulting in uniform shape and diameter, EZ-Spread plating beads ensure more even spreading of cells leading to increased colony formation compared to conventional methods.

Cancer Research Horizons opens nominations for its Innovation and Entrepreneurship Awards 2025

Cancer Research Horizons, the innovation arm of Cancer Research UK, has opened nominations for its Innovation and Entrepreneurship Awards 2025, which celebrate the UK’s most enterprising efforts in oncology by recognising the researchers and entrepreneurs who are making strides towards translating their innovations into effective treatments and diagnostics for the benefit of patients affected by cancer.

Subscribe to